knowledge -WSS

knowledge

author：entertainment 2025-09-28 09:06:00 - browse：8169

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Biden's 'march

WSS

What the airline industry can learn from medicine

Immune cells and nerve overgrowth may explain recurring UTI pain

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Breakthrough Alzheimer’s drugs are inaccessible in rural states

No plane should take off without an EpiPen onboard

Physician groups backed by private equity giant lobby on mergers

explore

knowledge

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: BridgeBio, Akero, and human embryo models

Jerome Adams on the need for new antivirals for Covid

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

FDA approval of Sarepta Duchenne genetic therapy gives me hope

National panel will explore requiring free Covid tests

Medical records are filled with copy

The public health thinking behind the CDC’s new Covid guidance

DIEP, the 'gold standard' of breast reconstruction, is under threat

Adults seen as increasingly susceptible to measles

explore

Micronoma's microbiome cancer diagnostic approach under fire

EQRx, failed developer of low

National panel will explore requiring free Covid tests

Change Healthcare: What is it, why does its cyberattack matter?

Mitch McConnell episode has important public health takeaway

Infectious disease expert Jeanne Marrazzo assumes Fauci role

focus

entertainment

Wikipedia

hotspot